Cerebras

Develops AI acceleration hardware and software

Sunnyvale, California, United States

About Cerebras

Cerebras Systems specializes in accelerating artificial intelligence (AI) processes with its CS-2 system, which is designed to replace traditional clusters of graphics processing units (GPUs). The CS-2 system simplifies AI computations by eliminating the need for complex parallel programming and cluster management, making the process more efficient. Clients from various sectors, including pharmaceuticals, government research labs, and industries like healthcare and finance, utilize the CS-2 to achieve faster results in critical applications such as drug response predictions. Cerebras generates revenue by selling its proprietary hardware and software solutions, including the CS-2 systems and related cloud services. The company's goal is to streamline AI training and inference, ultimately reducing the costs and time associated with AI research and development.

Sunnyvale, CaliforniaHeadquarters
2016Year Founded
$700.4MTotal Funding
SERIES_FCompany Stage
Data & Analytics, Enterprise Software, AI & Machine LearningIndustries
201-500Employees

Benefits

Professional Development Budget
Flexible Work Hours
Remote Work Options
401(k) Company Match
401(k) Retirement Plan
Mental Health Support
Wellness Program
Paid Sick Leave
Paid Holidays
Paid Vacation
Parental Leave
Family Planning Benefits
Fertility Treatment Support
Adoption Assistance
Childcare Support
Elder Care Support
Pet Insurance
Bereavement Leave
Employee Discounts
Company Social Events

Risks

Competition from NVIDIA and Graphcore could impact Cerebras' market share.
Rapid AI model evolution may necessitate frequent hardware updates, increasing R&D costs.
Supply chain vulnerabilities could delay production of Cerebras' hardware.

Differentiation

Cerebras' Wafer-Scale Engine is the largest chip ever built for AI.
The CS-2 system replaces traditional GPU clusters, simplifying AI computations.
Cerebras serves diverse industries, including pharmaceuticals and government research labs.

Upsides

Growing AI model efficiency demand aligns with Cerebras' energy-efficient accelerators.
AI democratization increases need for user-friendly systems like Cerebras' CS-2.
Pharmaceutical industry's push for faster drug discovery boosts demand for Cerebras' technology.

Funding

Total raised$700.36 M
Latest valuation$4.00 B
StageSERIES_F